QA: Teligent Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000352998_2019_Teligent_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.0001571322320109783, 'aggregate_val': 190892000, 'exp_sum': 190922000, 'exp_to_value': {'AssetsCurrent': 48386000, 'IntangibleAssetsNetIncludingGoodwill': 48875000, 'PropertyPlantAndEquipmentNet': 91775000, 'remainder_Assets': 1886000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000352998, Teligent Inc.

  xvar xval
0 AssetsCurrent 48,386,000
1 IntangibleAssetsNetIncludingGoodwill 48,875,000
2 PropertyPlantAndEquipmentNet 91,775,000
3 remainder_Assets 1,856,000
4 LiabilitiesCurrent 32,612,000
5 LiabilitiesNoncurrent 73,000
6 remainder_Liabilities 139,786,000
7 CostOfGoodsAndServicesSold 43,480,000
8 SellingGeneralAndAdministrativeExpense 23,408,000
9 ResearchAndDevelopmentExpense 14,076,000
10 remainder_Expenses 5,450,000
11 remainder_Revenues 65,865,000
12 remainder_NetIncome -15,669,000
13 remainder_ComprehensiveNetIncome -631,000
  yvar yval
0 Assets 190,892,000
1 Liabilities 172,471,000
2 Expenses 86,414,000
3 Revenues 65,865,000
4 StockholdersEquity 18,421,000
5 NetIncome -36,218,000
6 ComprehensiveNetIncome -36,533,500
7 BaseVar 265,971,000
8 EconomicCapitalRatio -0.0267

Edgar->Model Mapping

Feature Distribution

Change over Time